Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare efficacy and tolerability of the dydrogesterone and the vaginal progesterone, used for luteal phase support.

(Initial start date was January 2009 but not for patients' recruitment only for paper work, documents, team organization, statistical pre-work actions and to gain the official approval of Institutional Review Board. The recruitment started in October 2010 and continued until October 2013.)

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Zagreb
• Treatments: Dydrogesterone; Progesterone

Criteria

Inclusion Criteria:

• routine ovulation induction protocol with GnRH agonist

• less than three prior IVF cycles

• at least three aspirated oocytes

• BMI <35 kg/m2

• age <45 years

Exclusion Criteria:

• history of dysfunctional uterine bleeding

• acute urogenital disease

• recurrent miscarriage

• previous allergic reactions to a progesterone products